Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 54 results for "biocon under kiran mazumdar shaw"

Eyeing richer valuations for Syngene before listing: Biocon

Also, Kiran Mazumdar Shaw is disappointed by the process adopted by NPPA to add drugs under price control list. Money Control, 3 hours ago

9 images for biocon under kiran mazumdar shaw

APN News, 1 month ago
Financial Express, 1 month ago
Business Standard India, 3 weeks ago
news.oneindia.in, 3 weeks ago
NDTV, 1 month ago
Rediff.com, 1 month ago
Reuters, 2 months ago
New Indian Express, 1 month ago
Asian Scientist, 2 months ago
Financial Express

Looking to commercialise insulin Glargine by 2018: Biocon

Kiran Mazumdar Shaw CMD Biocon The Indian research and development pharma company that developed this biosimilar drug and later on partnered Mylan to develop it further, will start receiving royalties once the insulin Glargine gets completely ...
 Moneycontrol.com2 days ago Biocon up 3% post Mylan's phase-3 trials for Glargine  Moneycontrol.com2 days ago Heal pharma sector, Kiran Mazumdar urges PM  Smart Investor1 month ago NPPA's unilateral stand-off unhealthy for sector: Biocon  Moneycontrol.com1 month ago

Biocon Announces Q1 FY15 Results

Commenting on the quarterly performance and highlights, Chairman and Managing Director, Kiran Mazumdar-Shaw stated, Our revenue growth this quarter has been muted. Our business performance reflects the challenges that we are temporarily facing in ...
 Businessworld India1 month ago Biocon : announces Q1 FY15 results...  4 Traders1 month ago
NDTV Profit

Industry Body Seeks Prime Minister's Intervention Over Drug Price Fixing

File photo of Biocon chief Kiran Mazumdar-Shaw New Delhi : Industry chamber CII has sought Prime Minister Narendra Modi's intervention over "unilateral fixing" of drug prices by the National Pharmaceutical Pricing Authority (NPPA) saying the ...
 NDTV Profit1 month ago
Moneycontrol.com

Price control debate: Is the pharma sector crying 'wolf'?

T Also Read: See more drug price caps; max impact on Sanofi: Expert CNBC-TV18's Shereen Bhan spoke to Kiran Mazumdar Shaw, CMD of Biocon and Mr CM Gulati, Researcher at IMS Health India to get their perspective on how the government's new move ...
 Moneycontrol.com2 months ago

Biocon chief seeks PM's intervention to solve issues being faced by pharma industry

The National Pharmaceutical Pricing Authority's (NPPA) decision to impose ceiling prices on 348 essential drugs under the National List of Essential Medicines (NLEM), by adopting a simple average price formula, has been to the industry's ...
 PharmaBiz1 month ago
Deccan Chronicle

Guru Utsav: Old Cottonians to make it special for fave teachers

In a very unique, heartwarming initiative undertaken by the Old Cottonian's Association, alumni from all over the world have been called upon to send in a message to the teachers Bengaluru: What would we all be without our teachers? That is the ...
 Deccan Chronicle2 weeks ago
Sify

Biocon net up by 10% in Q1 to Rs. 103 crore

Biocon, a Rs. 2,850 crore plus fully integrated, innovation-led, emerging global biopharmaceutical company from Bengaluru, has posted net profit growth of 9.6 per cent for the first quarter ended June 2014 to Rs. 103 crore from Rs. 94 crore in the ...
 PharmaBiz1 month ago Biocon Q1 net up 9%  Business Standard India1 month ago

BIOCON : files first new drug applications

Mumbai : Bangalore -based Biocon on Friday said it has filed its first abbreviated new drug applications (ANDAs) targeting the US generics market during the June quarter. Kiran Mazumdar-Shaw , chairman and managing director, said, "We have filed ...
 4 Traders1 month ago Biocon files its first new drug applications  DNA India1 month ago Biocon files first new drug applications [DNA : Daily News & Analysis (India)]  Pharmacy Choice1 month ago

West Asia turmoil mutes Biocon's earnings in Q1

BANGALORE: Biocon reported a modest 9% growth in profit on a 3% growth in revenue for the April to June first quarter of fiscal 2015, as compared to the same period a year ago. Challenges in the key growth markets of Middle East and North Africa ...
 Times of India1 month ago Biocon : West Asia turmoil mutes Biocon's earnings in Q1  4 Traders1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biocon under kiran mazumdar shaw
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less